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A qualitative study exploring patient, family carer and healthcare professionals direct 
experiences and barriers to providing and integrating palliative care for advanced head 
and neck cancer 
 
ABSTRACT (Word count 250) 
 
Objectives: To report on direct experiences from advanced head and neck cancer patients, 
family carers and healthcare professionals, and the barriers to integrating specialist palliative 
care.  
Methods: Using a naturalistic, interpretative approach, within Northwest England, a 
purposive sample of adult head and neck cancer patients was selected. Their family carers 
were invited to participate. Healthcare professionals (representing head and neck surgery and 
specialist nursing; oncology; specialist palliative care; general practice and community 
nursing) were recruited. All participants underwent face-to-face or telephone interviews. A 
thematic approach, using a modified version of Colazzis framework, was used to analyse the 
data.  
Results: Seventeen interviews were conducted (nine patients, four joint with family carers 
and eight healthcare professionals). Two main barriers were identified by healthcare 
professionals: lack of consensus about timing of Specialist Palliative Care engagement and 
high stake decisions with uncertainty about treatment outcome.  The main barrier identified 
by patients and family carers was lack of preparedness when transitioning from curable to 
incurable disease. There were two overlapping themes from both groups: uncertainty about 
meeting psychological needs and misconceptions of palliative care.  
Conclusions: Head and neck cancer has a less predictable disease trajectory, where complex 
decisions are made and treatment outcomes are less certain. Specific focus is needed to define 
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the optimal way to initiate Specialist Palliative Care referrals which may differ from those 
used for the wider cancer population.  Clearer ways to effectively communicate goals of care 
are required potentially involving collaboration between Specialist Palliative Care and the 
wider head and neck cancer team.  
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INTRODUCTION 
Head and neck cancer (HNC) has unique complexities due to its effects on eating, speaking 
and breathing. [1-3] This results in prevalent, diverse symptoms [2, 4] with complex pain 
often experienced.[4] Issues with speech can cause difficulties with expressing needs, 
impacting on involvement with decision-making. Altered facial appearance, [5, 6] distressing 
symptoms and social isolation can contribute to depression and a higher risk of suicide.[7] 
Family members report distress and unmet needs. [8, 9] Globally, poverty and deprivation 
impact on care access.[10, 11] 
Specialist Palliative Care (SPC) input with HNC patients may be underutilised, despite the 
improved symptom control and patient experience when SPC is introduced early into 
oncological care.[12-14] Within the UK, only 25% of HNC multi-disciplinary team (MDT) 
meetings have direct SPC presence[15] although this may relate to meetings being focused on 
initial diagnosis and treatment plans. In one retrospective, national study, conducted within 
the U.S.A., only 5% of hospitalised metastatic HNC patients received a SPC consultation. 
[16] In other studies, referral for SPC input within the hospital or for hospice care could be 
late in the course of the disease. [17, 18] Variability in accessing services for age and gender 
has been seen for HNC patients. [16, 18].  More widely, low socio-economic groups 
experience barriers in access to SPC services [19], which is especially pertinent for HNC 
patients, where socio-economic status is a recognised factor in both incidence and survival. 
[20, 21] 
 
There are many barriers to integrating palliative care into cancer care: [22] lack of 
oncologists awareness or knowledge about palliative care;[23] lack of effective 
communication between healthcare professionals and patients (e.g. goals of care);[24] limited 
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palliative care resources;[24] societal misconceptions about palliative care meaning end-of-
life;[24] and lack of sufficient research funding. No studies have explored the specific 
challenges affecting HNC patients. The aim of this study was to identify the main barriers to 
integrating SPC within routine oncological care, as perceived by HNC patients, their family 
carers and healthcare professionals (HCP). The following definition is used for SPC: multi-
disciplinary teams comprised of individuals who have undertaken specific expert training 
focused on palliative care needs which cannot be met by patients usual healthcare team; SPC 
teams may operate within the UK hospital, community or hospice setting. 
 
METHODS  
We adopted a naturalistic, interpretative approach[25] to enable a rich understanding of 
experiences and perceptions.[26]   
Study setting  
Within the UK, HNC care is based on a centralised multidisciplinary model with service 
integration advocated via a key worker role and usually facilitated by a specialist HNC 
nurse [27]. National recommendations advise all professionals caring for HNC patients assess 
palliative and supportive care needs throughout the illness, including at initial treatment 
planning, and recognise when SPC expertise is required [28]. A weekly, regional MDT 
meeting occurs within Northwest England which discusses all new and recurrent HNC 
patients (average 70 patients/month; eight treated with palliative intent). Regionally, SPC 
services, funded through public and charitable sources, provide advisory input to community 
settings (home, care home or out-patient clinic) working with other generic palliative 
caregivers e.g. General Practitioners and District Nurses (community doctors and nurses).  
Advisory SPC input is provided within acute hospitals, working with core professionals from 
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the HNC MDT, or SPC teams are directly responsible for care within a SPC in-patient unit or 
hospice.  
 
Participant selection  
Patients and family carers 
 
Adult patients (over 18 years) with a histological or radiological diagnosis of advanced 
HNC and aware of their diagnosis (as reported by the clinical team) were purposively 
sampled [29]. Advanced HNC incorporated those with incurable disease, and those treated 
curatively but whom the clinical team judged were high risk for developing recurrent 
disease. Those unable to provide informed consent, perceived to be unduly distressed by 
participation (either by the clinical or research team), or who lived out with the region (and so 
a face-to-face interview would be burdensome) were excluded. Identification was conducted 
by clinical teams during HNC MDT meetings, via out-patient clinics and SPC services in 
hospitals and hospices, who provided initial study information and permission for the 
research team to make contact. Opportunities for further information and questions were 
provided. For each patient, where possible, the family carer was asked if they wished to 
participate.  
 
Health care professionals  
 
Potential participants were identified using a word-of-mouth snowball sampling strategy 
which is recognised to benefit inductive, theory-building analysis.[29] Existing linkages 
with the HNC MDT identified potential community participants. Initially, we aimed to gain 
views from at least one representative working within HNC Surgery; Oncology; SPC; 
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General Practice and Community Nursing. Review of this, deemed that HNC Clinical Nurse 
Specialist experiences would further enrich the data, in keeping with the concept of 
information power[30], which is an alternative approach to the data saturation concept.  
Those wishing to know more about the study, either made direct contact with the research 
team or passed on their details via existing participants.  
 
Ethics approval  
Ethical approval was obtained from the Health Research Authority and the North West -
Greater Manchester West Research Ethics Committee (REC 17/NW/0083; IRAS project ID 
221772). All participants received a Participant Information Sheet and provided written 
informed consent.    
 
Data collection  
Patient data were collected from case records and included demographic details; Eastern 
Cooperative Oncology Group (ECOG) performance status;[31] primary diagnosis; presence 
of metastatic disease; and treatment intent. Family carer data included gender and 
relationship to patient. Details for HCPs included gender; age; and time working in current 
area of practice.  
 
Interviews   
Semi-structured digitally recorded interviews were conducted in a place convenient for the 
patient (home, hospital or hospice). Either face-to-face or digitally recorded telephone 
interviews (a logistical, flexible solution to those who work across a wider geographical area) 
[32] were offered for HCPs. All interviews were conducted by one researcher between June 
and November 2017. Patient and family carer interviews ranged from 8 to 114 minutes (mean 
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45 minutes). For two patients, verbal communication was especially challenging, so written 
communication supplemented the interview (and was directly checked with the participant 
for accuracy). The HCP interviews ranged between 23 and 55 minutes (mean 39 minutes). 
Field notes were captured immediately after the interviews.     
 
Exploratory topics within the interview schedule (Supplementary file 1) focused on 
experiences of HNC and specific challenges to integrating SPC. The interview schedule was 
reviewed and tested by the research team which included medical, nursing, psychology and 
patient representation.   
 
Analysis  
Demographic data were analysed descriptively and recorded interviews were transcribed 
verbatim and anonymised during this process. For the two patients where verbal 
communication was challenging, a written record was documented by the researcher. A 
thematic approach to analysis was conducted using the modified principles of Colazzis 
framework,[33] namely: organisation; familiarisation; reduction; and analysis.  
 
To enhance rigour, two researchers independently analysed each transcript to familiarise 
themselves with the data, recorded initial analytical notes and checked field notes. An 
inductive approach to coding was used. Both researchers met to compare initial analysis and 
group the codes together into categories. Data relating to the main research question, the 
barriers to integrating palliative care, was used as a framework for charting further analysis. 
Additional discussion, data reduction and analysis across cases was conducted with a third 
researcher. A final coding scheme was agreed leading to identification of themes and 
subthemes. All participants were allocated a unique identifier code with participants quotes 
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used to support findings. For the two patients (P1 and P5), where verbal communication was 
challenging, written communication was incorporated to supplement the interview, and this is 
indicated by an asterix (*). 
 
RESULTS  
 
Participants 
From 38 eligible patient participants, ten agreed to be interviewed (Figure 1). One patient 
died prior to the interview, resulting in a sample of nine patients. Seven participants were 
male, and all were aged between 57 and 88 years. There was a wide range of different cancer 
sites and four participants had distant metastatic disease (Table 1).  
 
Four family carers consented to a joint interview, three of whom were female and all were the 
patients spouse (Table 1). The remaining family members either could not be identified or 
declined participation. Eight HCPs were interviewed, with an equal gender split and their 
length of time working in healthcare ranged from 15-32 years (Table 2).  
 
Themes  
The two main barriers identified by HCPs were lack of consensus about timing of Specialist 
Palliative Care engagement and high stake decisions with uncertainty about treatment 
outcome.  The main challenge identified by patients and family carers was lack of 
preparedness when transitioning from curable to incurable disease. Additionally, there were 
two overlapping themes from both groups, uncertainty about meeting psychological needs 
and misconceptions of palliative care.  
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Healthcare professionals themes 
Lack of consensus about timing of Specialist Palliative Care engagement  
 
There was uncertainty about the optimum time to commence SPC engagement with 
recognition that issues could arise when referral was late.  
 
. I have seen people who have clearly been symptomatic for long periods of time, 
whereby symptom control isnt possibly as good as it could have been if there was 
help alongside the way by a specialist. (HCP2) 
 
Engagement with SPC, however, could be perceived as too early in the disease trajectory 
which was especially challenging for patients still being considered for potentially curative 
treatment.   
 
for our locally advanced patients, to offer surgery, but the survival is going to be 
what, 40% overall survival, and personally I have always been a bit conflicted about 
whether you should confront these people with palliative type discussions at this 
stage. (HCP3) 
 
The issue of appropriateness of SPC referral was raised where the treatment intent was 
palliative but the patient didnt have overt complex needs.  
 
I referred them in a manner which said, look, I would rather you were involved 
earlier.  There may be very little for you to do but I think this person should be on 
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your radarAnd the letter I got back just didnt, just didnt seeOh well, theres 
not much for us to do at this place in time (HCP5) 
 
This raised questions about who was best placed to provide supportive care needs and 
whether this fell within the SPC remit or was the responsibility of the HNC MDT.   
 
The other group of patients that I often see as well, probably more so than my 
colleagues in other areas, is that I get referred patients that have undergone curative, 
or potentially curative treatment for the head and neck cancer, and there doesnt 
seem to be anywhere for them to go. (HCP7) 
 
theres a need for some support.It might not necessarily be, erm, palliative 
support, but certainly some, erm, very experienced cancer support.is very good for 
patients because theyve got lots of, lots of questions. (HCP8) 
 
Overall, further clarity and consensus to streamline SPC referral processes was welcomed.    
 
 .more training would definitely help and trigger what in terms of who to refer to and 
who may be suitable for each patient would definitely help too. (HCP6) 
 
High stakes decisions with uncertainty about treatment outcomes 
Participants reflections conveyed the complexity of decision-making, the unpredictable 
outcomes and the challenges of advance care planning.  
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.we take them on for what we hope is good palliative surgery, and they get 
complications and they end up stuck in hospital for weeks, or they die in hospital, and 
that in hindsight was a mistake. So, these are high stakes decisions. (HCP3)  
This could result in difficulty communicating the relevant information to patients and family 
carers.  
Im not that convinced that they are really, that the, the sequelae and the side effects 
of treatment are adequately explained to the patient, that they can really understand 
what, what its going to feel like.  (HCP5) 
Healthcare professionals could be left wondering how effective their consultations were in 
terms of information provision.   
 Sometimes I wonder how well these conversations go, and I look around the room 
as if to say you know, How successful was that conversation? I dont know. (HCP1)  
 
Patient and family carers themes 
Lack of preparedness when transitioning from curative to incurable disease  
 
Both patients and family carers shared experiences where they perceived communication and 
preparedness was lacking at this critical moment.  
 
In that consultation when I found out I was terminal, I felt that there should have 
been an additional appointment, or something so that my family could be there and 
we could discuss it all as a team. (P1*) 
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you know, if Dr (doctors name) said go away and absorb the information, Ill set 
up for you to come back in a weeks timeIll arrange for you to see a palliative 
consultant, that would have been to my mind..a really good way of managing a 
very difficult situation.. (P9) 
Another participant spoke about how unprepared they felt for receiving bad news.  
 
until yesterday or the day before, I had no idea they were going to say you know, 
well this is it and you only have a few weeks, I had no idea that was going to happen 
at all. (P6) 
 
In some situations, there was a desire to have more specific information. One family carer 
reflected on their wish for details about prognosis.  
 
. He did ask how long do I have left and he did say well I cant give you years, I 
could give you months, I could give you 12, I could give you 3. I dont know. So, 
youre always coming out of those places thinking, oh I wish, but I dont think they 
even know themselves to be frank. Then you think, well you see this everyday so come 
on, you must know something. (FC2) 
 
Overlapping themes 
Uncertainty about meeting psychological needs 
 
Both patients and HCPs recognised that emotional support was an area of great importance.   
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Psychological support is, is something thats really necessary, especially if theyve 
had quite sort of, like, mutilating surgery (HCP5) 
 
It was also recognised as an area of care which could be improved, for both patients and 
family carers.  
Psychologically I find they need a lot of support..........sometimes they could do with 
more. (HCP8) 
 
 I dont feel that she (my partner) has had enough support, and I do worry about that..I 
think thats where you would need the HCPs to be even more supportive to these people, and 
so they get the additional support they need.. (P1*) 
 
It was not clear, however, who should be providing this support. Rather the importance was 
placed on someone being there to listen.  
 
..just, having somebody to explain or ask you what your fears are (P7) 
 
I wish that when I was diagnosed I could have been put in the direction of a head and 
neck support team, with people that have been through this. (P2) 
 
Misconceptions about palliative care  
 
Societal misconceptions about palliative care representing death and dying were widely 
reported.  
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.weve told friends that (patients name) seen a palliative care consultant and you 
can see them going..as if palliative care is in the last six weeks of your life. (FC9) 
 
Misconceptions were not only isolated to the general public, however, but were also 
recognised within HCPs.   
 
the District Nurse who we saw first, I think was quite an experienced district 
nurse, clearly though the way that most people think about palliative care, is that 
theyre the people that come in in the last six weeks of life (P9) 
 
Fears about palliative care could mean a reluctance for patients to engage with services.  
 
sometimes patients are like no, no, no, I dont want that, so we let the GP know 
we have offered that service, they just dont want it at the moment. (HCP4) 
 
DISCUSSSION 
 
Our study findings indicate the main barriers to integrating SPC within routine oncological 
care relate to the unique complexities of HNC, the decision-making and the uncertainties 
about treatment outcome. This means it is more challenging to identify the right HNC 
patient at the right time who would most benefit from SPC services potentially compared 
with other cancers. Patients and family carers perceive that increased preparedness for 
disease transitions and more psychological support are needed. The individual responsibility 
for the provision of this support wasnt clearly defined. This study also confirms societal 
misconceptions about palliative care are also prevalent within a HNC context.  
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The importance of timely identification of patients who may benefit from SPC is widely 
recognised. Referrals that are too late can deny patients the full benefit of SPC e.g. timely 
symptom management and advance care planning. Equally, referrals that are too early may 
result in patients with few concerns being seen by SPC.[34] The transition from curative to 
non-curative disease can be ill-defined and the disease trajectory for HNC patients is 
especially complex.[35]  A national study identified a cohort of HNC patients, who after 
initially receiving curative treatment, were quickly recognised to have residual or recurrent 
cancer and required a palliative care focus[36]. Hence, there may be specific periods when 
the patient might benefit from a targeted SPC input focused on symptom control, even 
although the intent of treatment is curative.[37] It is not feasible, however, for every HNC 
patient being treated with palliative intent to receive input from a relatively scare specialist 
resource. 
 
This links with Quill and Abernethys coordinated palliative care model where 
contributions from both specialists and non-specialists in palliative care are valued [38]. The 
model distinguishes primary palliative care skills (skills which all clinicians should have) 
from specialist skills (those for managing more complex, challenging situations) but enables 
both to work together in a collaborative manner [38]. The primary care or treating specialist 
would lead the initial palliative care, involve the SPC team for complex or intractable issues, 
and then continue the ongoing care if, and when, the issues were resolved. The European 
Association for Palliative Care (EAPC) has provided recommended levels of education in 
palliative care to support this model [39].   
 
Despite national recommendations that all core HNC MDT members should have advanced 
communication skills,[28] issues were identified relating to the information provision and 
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goals of care. This is similar to another study exploring the communication of prognostication 
information to HNC patients.[40] Issues identified related to medical jargon, paternalism and 
the omission of specific prognostic information.[40] Additionally, HNC patients can have a 
reluctance to engage with advance care planning due to their focus on treatments which 
increase the longevity of life [41] and differences in preferences about the level of 
information they desire.[42]  
 
A systematic review reported that factors promoting good partnership working between 
specialists and non-specialists in palliative care included: clear definition of roles and 
responsibilities; good communication; shared learning and education; appropriate, timely 
SPC access and coordinated care. [43] Our study findings would suggest clarity about roles 
for providing psychological support is important. Additionally, in the context of complex 
HNC decisions, uncertain treatment outcomes and emerging immunotherapy treatments,[44] 
another area of focus and collaboration would be defining and effectively communicating 
goals of care.  
 
The optimal way to incorporate palliative care in the multidisciplinary management of 
patients with high risk squamous cell cancer of the head and neck remains unclear.[45] 
Internationally, to help gain consensus on who should be referred and the optimal timing of 
SPC out-patient referral, a Delphi study was conducted.[34] This defined 11 major needs- 
and timing-based referral criteria. In view of the less predictable disease trajectory, criteria 
such as these need further validation within the HNC remit to see if they provide timely and 
appropriate SPC referrals. Additionally, although there are a number of models promoting 
palliative care integration within oncological care, including time-, provider-, issue-, or 
system-based models,[12] it is unclear which are the most appropriate for HNC patients. 
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Investment into research funding is required to evaluate specific interventions which promote 
high quality care and good communication. As HNC is associated with aggressive 
interventions at the end-of-life,[46, 47] a focus on cost-effective use of healthcare resources 
would also be pertinent.  
 
Strengths and limitations 
 
This study has several strengths. Firstly, data from patients, family carers, and HCPs enabled 
multiple perspectives to be obtained, bringing breadth and depth to the study. The researcher 
conducting the interviews had a psychology background potentially enabling a more open 
approach to both positive and negative care experiences. Although previous studies have 
explored challenges to integrating palliative care, none have specifically focused within a 
HNC population. Many HNC qualitative studies have assessed issues earlier in their disease 
trajectory.[8, 48] By engaging with advanced HNC patients, they represent a hard to reach 
group.   
 
There were limitations to the study. Firstly, we did not recruit any patients who had been 
treated with curative intent but were recognised to be high risk for recurrence. There may 
have been a degree of healthcare professional gatekeeping and a reluctance to consider 
those who were not already linked into SPC services in case participation potentially caused 
distress. Their viewpoint could have helped identify additional challenges faced earlier in the 
illness.  Secondly, due to difficulties with verbal communication, one patient interview was 
very short. Limiting the study to only those who were verbally articulate, however, did not 
seem ethically appropriate. Thirdly, member checking of the transcripts was not deemed to be 
practical due to the advancing illness and the limited time available for the HCPs. Finally, the 
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study was conducted within one healthcare system and further research would be valuable to 
explore barriers within different countries and systems.  
 
CONCLUSION 
HNC reflects an illness with a less predictable disease trajectory, where highly complex 
decisions are made and treatment outcomes can be less certain. A specific focus needs to be 
given to the optimal way to initiate SPC referrals which may not be in keeping with those 
used for the wider cancer population.  Clearer ways to effectively communicate the goals of 
care are required potentially adopting a collaborative approach between SPC and the wider 
HNC MDT earlier in the disease trajectory.  
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HCP  healthcare professionals 
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Table 1. Patient and family carer participants demographic and clinical details 
 
Participant  Gender  
Age 
range 
ECOG 
status 
Presence 
of distal 
metastatic 
disease * 
Treatment 
intent 
Place of care 
at time of 
interview 
Family carer 
(FC) 
interviewed 
FC gender  
FC 
relationship 
to patient 
P01  Male  70-79  
Not 
recorded 
Yes  Palliative  Hospice  No  N/A  N/A 
P02  Male  60-69  2  No  Palliative  Home  Yes (FC2)  Female  Wife 
P03  Female  50-59  3  Yes  Palliative  Hospice  No  N/A  N/A 
P04  Male  80-89  2  No  Palliative  Hospital  No  N/A  N/A 
P05  Male  60-69  1  Yes  Palliative  Hospital  No  N/A  N/A 
P06  Male  80-89  1  No  Palliative  Hospital  No  N/A  N/A 
P07  Female  60-69  2  Yes  Palliative  Home  Yes (FC7)  Male  Husband 
P08  Male  60-69  
Not 
recorded 
No  Palliative  Home  Yes (FC8)  Female  Wife 
P09  Male  60-69  2  Yes  Palliative  Home  Yes (FC9)  Female  Wife 
*Specific details of primary cancer site have not been given to protect anonymity but included oropharynx, hypopharynx, tongue, mandible, and parotid gland. 
N/A = not applicable 
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Table 2. Healthcare professionals demographic details (n=8) 
 
Demographic  Number or range 
Gender  
Male n=4 
Female n=4 
Age range  38  60 years 
Length of healthcare experience  15 - 32 years 
Length of time working with head and 
neck cancer patients 
4  27 years 
Current area of work  
Specialist Palliative Care n=2 
Community Care n=2 
General Practitioner n=1 
Community Nursing n=1 
Head and Neck Cancer Multi-Disciplinary 
Team members n=4 
Oncology n=1 
Surgery n=2 
Clinical Nurse Specialist n=1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 1: Flow diagram illustrating patient recruitment 
 
  
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
n = 4 family carers located and 
agreed to be interviewed  
Potential eligible patient 
participants 
(n = 38) 
Agreed to be contacted by 
researcher     
(n = 22) 
Contacted but not recruited (n = 12) 
 
n = 6 patients died                                                        
n = 4 did not wish to take part  
n = 2 did not respond 
Agreed to take part                    
(n = 10) 
n = 1 patient died prior to interview                      
Interviews undertaken                 
(n = 9) 
Excluded (n = 16) 
n = 5 died                                                                  
n = 2 too unwell                                                
n = 6 clinician perceived 
patient would find too 
distressing / not able to 
complete study requirements                                                                                                 
n = 3 lived out of area                                                          
 
